Cabot (NYSE:CBT) Stock Rating Upgraded by StockNews.com

Cabot (NYSE:CBT) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Tuesday.

CBT has been the topic of a number of other reports. JPMorgan Chase & Co. dropped their price target on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Mizuho cut their price target on Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $97.00.

Cabot Stock Performance

NYSE CBT opened at $84.40 on Tuesday. The company has a market capitalization of $4.58 billion, a PE ratio of 11.21, a P/E/G ratio of 0.74 and a beta of 1.21. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. Cabot has a 1 year low of $79.57 and a 1 year high of $117.46. The company has a fifty day moving average of $85.23 and a two-hundred day moving average of $97.76.

Cabot (NYSE:CBT) last announced its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, analysts expect that Cabot will post 7.57 earnings per share for the current year.

Institutional Trading of Cabot

A number of hedge funds and other institutional investors have recently modified their holdings of CBT. Norges Bank purchased a new position in shares of Cabot in the fourth quarter worth approximately $37,961,000. Millennium Management LLC boosted its stake in shares of Cabot by 67.7% during the 4th quarter. Millennium Management LLC now owns 349,369 shares of the specialty chemicals company’s stock worth $31,901,000 after acquiring an additional 141,050 shares in the last quarter. Copeland Capital Management LLC grew its holdings in Cabot by 21.6% during the fourth quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company’s stock valued at $69,521,000 after purchasing an additional 135,119 shares during the last quarter. American Century Companies Inc. raised its holdings in Cabot by 8.5% in the 4th quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company’s stock worth $120,835,000 after acquiring an additional 103,380 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of Cabot by 27.1% during the 4th quarter. JPMorgan Chase & Co. now owns 451,513 shares of the specialty chemicals company’s stock worth $41,228,000 after purchasing an additional 96,179 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.